Início › Câncer Colorretal › Kansas
Ensaios clínicos de Câncer Colorretal em Kansas
19 estudos para Câncer Colorretal estão buscando participantes em locais em Kansas.
Cidades em Kansas
- Overland Park8 estudos
- Kansas City6 estudos
- Wichita4 estudos
- Topeka3 estudos
- Garden City3 estudos
- Pittsburg3 estudos
Texto oficial do estudo (Inglês)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Central Care Cancer Center - Garden City, Garden City
- Central Care Cancer Center - Great Bend, Great Bend
- Veteran Administration Eastern Kansas Healthcare, Leavenworth
- e mais 4
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades de 40 a 75 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05334069Family Communications After Genetic Testing
- Central Care Cancer Center - Garden City, Garden City
- Central Care Cancer Center - Great Bend, Great Bend
- Mercy Hospital Pittsburg, Pittsburg
- e mais 1
RecrutandoVoluntários saudáveis bem-vindos
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT07143487Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
- University of Kansas Clinical Research Center, Fairway
- University of Kansas Cancer Center, Kansas City
- University of Kansas Hospital-Westwood Cancer Center, Westwood
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT05803382Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
- Research Site, Westwood
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06218914A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
- Cancer Center of Kansas, Wichita
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06750094A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
- Cancer Center of Kansas, Wichita
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06662786Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
- University of Kansas, Fairway
RecrutandoFase 1
Idades de 12 a 120 · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT04222413Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- The University of Kansas Clinical Research Center, Westwood
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT06445062Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer
- University of Kansas Clinical Research Center, Fairway
- University of Kansas Cancer Center, Kansas City
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- e mais 1
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 9 de set. de 2026 · NCT06696768Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
- Clinical Study Site, Westwood
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 8 de set. de 2026 · NCT07228832A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- The University of Kansas Cancer Center, Kansas City
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 11 de ago. de 2026 · NCT05592626Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
- University of Kansas Clinical Research Center, Fairway
- University of Kansas Cancer Center, Kansas City
- University of Kansas Cancer Center-Overland Park, Overland Park
- e mais 2
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 31 de jul. de 2026 · NCT05691491Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
- Cancer Centers of Kansas, Wichita
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 15 de jul. de 2026 · NCT06937177Lead-212 PSV359 Therapy for Patients With Solid Tumors
- University of Kansas, Kansas City
RecrutandoFase 1/2
Idades de 18 a 90 · Todos os sexos · Atualizado em 6 de jul. de 2026 · NCT06710756Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease
- The University of Kansas Clinical Research Center, Fairway
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 1 de jun. de 2026 · NCT06607458Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
- Central Care Cancer Center - Garden City, Garden City
- Central Care Cancer Center - Great Bend, Great Bend
- Mercy Hospital Pittsburg, Pittsburg
RecrutandoFase 3Voluntários saudáveis bem-vindos
Idades 18 e acima · Todos os sexos · Atualizado em 31 de mar. de 2026 · NCT07018869A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
- The University of Kansas Cancer Center, Fairway
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 18 de mar. de 2026 · NCT06244771Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- HaysMed, Hays
- Lawrence Memorial Hospital, Lawrence
- The University of Kansas Cancer Center - Olathe, Olathe
- e mais 6
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 17 de mar. de 2026 · NCT06418204A Study of IBI363 in Subjects with Advanced Solid Malignancies
- University of Kansas Medical Center (KUMC), Fairway
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 19 de dez. de 2024 · NCT06281678Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.